CCO Oncology Podcast

185 Odcinki

1. Developments in Acute Leukemias: Expert Answers to Clinician Questions

   Opublikowany: 2.10.2020
2. Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy

   Opublikowany: 2.10.2020
3. Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond

   Opublikowany: 2.10.2020
4. Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC

   Opublikowany: 21.09.2020
5. The Art of Medicine: Clinical Considerations for Patients With Advanced RCC

   Opublikowany: 21.09.2020
6. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

   Opublikowany: 17.09.2020
7. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3

   Opublikowany: 17.09.2020
8. Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC

   Opublikowany: 17.09.2020
9. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2

   Opublikowany: 16.09.2020
10. CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

    Opublikowany: 14.09.2020
11. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

    Opublikowany: 8.09.2020
12. FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma

    Opublikowany: 3.09.2020
13. New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments

    Opublikowany: 1.09.2020
14. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

    Opublikowany: 31.08.2020
15. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

    Opublikowany: 31.08.2020
16. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

    Opublikowany: 28.08.2020
17. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2

    Opublikowany: 28.08.2020
18. Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies

    Opublikowany: 27.08.2020
19. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL

    Opublikowany: 26.08.2020
20. Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond

    Opublikowany: 14.08.2020